RENAL CANCER RECURRENT

RENAL CANCER RECURRENT was reported 147 times

RENAL CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 1 0.0006
1 Actinomycin [EPC] 1 0.0005
2 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 1 0.0003
3 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 22 0.0002
5 Progestin Antagonist [EPC] 1 0.0002
6 Chloride Channel Activator [EPC] 2 0.0002
7 Provitamin D2 Compound [EPC] 5 0.0002
8 Somatostatin Analog [EPC] 1 0.0001
9 Glinide [EPC] 1 0.0001
10 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1 0.0001
11 Protease Inhibitor [EPC] 3 0.0001
12 Prostaglandin E1 Analog [EPC] 1 0.0001
13 Sulfonylurea [EPC] 7 0.0001
14 Rifamycin Antibacterial [EPC] 2 0.0001
15 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
16 Human Immunoglobulin G [EPC] 1 0.0000
17 Integrin Receptor Antagonist [EPC] 4 0.0000
18 Alkaloid [EPC] 1 0.0000
19 Aromatase Inhibitor [EPC] 4 0.0000
20 Kinase Inhibitor [EPC] 19 0.0000
21 Cholinergic Nicotinic Agonist [EPC] 2 0.0000
22 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
23 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
24 Purine Antimetabolite [EPC] 3 0.0000
25 alpha-Adrenergic Blocker [EPC] 4 0.0000
26 Interleukin-17A Antagonist [EPC] 1 0.0000
27 Parathyroid Hormone Analog [EPC] 3 0.0000
28 Topoisomerase Inhibitor [EPC] 2 0.0000
29 Opioid Agonist [EPC] 7 0.0000
30 Insulin [EPC] 1 0.0000
31 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
32 beta3-Adrenergic Agonist [EPC] 1 0.0000
33 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
34 Interleukin-23 Antagonist [EPC] 2 0.0000
35 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
36 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
37 beta-Adrenergic Blocker [EPC] 5 0.0000
38 Platelet Aggregation Inhibitor [EPC] 9 0.0000
39 Vitamin C [EPC] 6 0.0000
40 Proton Pump Inhibitor [EPC] 8 0.0000
41 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
42 Anti-epileptic Agent [EPC] 3 0.0000
43 Calcium [EPC] 2 0.0000
44 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
45 Janus Kinase Inhibitor [EPC] 2 0.0000
46 Corticosteroid [EPC] 16 0.0000
47 Alkylating Drug [EPC] 3 0.0000
48 Nonsteroidal Anti-inflammatory Drug [EPC] 16 0.0000
49 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
50 Amide Local Anesthetic [EPC] 1 0.0000
51 GLP-1 Receptor Agonist [EPC] 5 0.0000
52 Factor Xa Inhibitor [EPC] 3 0.0000
53 Interferon beta [EPC] 2 0.0000
54 Antiarrhythmic [EPC] 1 0.0000
55 Vitamin D [EPC] 3 0.0000
56 5-alpha Reductase Inhibitor [EPC] 1 0.0000
57 Expectorant [EPC] 2 0.0000
58 Interleukin-12 Antagonist [EPC] 1 0.0000
59 Vitamin B12 [EPC] 3 0.0000
60 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
61 Mood Stabilizer [EPC] 2 0.0000
62 Loop Diuretic [EPC] 4 0.0000
63 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
64 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
65 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
66 Platinum-based Drug [EPC] 2 0.0000
67 Benzodiazepine [EPC] 5 0.0000
68 Prostacycline Vasodilator [EPC] 1 0.0000
69 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
70 Azole Antifungal [EPC] 1 0.0000
71 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
72 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
73 Thiazide Diuretic [EPC] 1 0.0000
74 Insulin Analog [EPC] 2 0.0000
75 Atypical Antipsychotic [EPC] 2 0.0000
76 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
77 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
78 Osmotic Laxative [EPC] 1 0.0000